Role of nitric oxide in histamine-induced increases in permeability of the blood-brain barrier

Brain Res. 1996 Dec 16;743(1-2):70-6. doi: 10.1016/s0006-8993(96)01021-9.

Abstract

While previous studies have examined the effects of histamine on the permeability of the blood-brain barrier and reactivity of cerebral blood vessels, cellular mechanisms which account for histamine-induced affects on the cerebral microcirculation are not clear. The goals of this study were to determine the role of nitric oxide in histamine-induced increases in permeability of the blood-brain barrier and dilatation of pial arterioles. We examined the pial microcirculation in rats using intravital fluorescence microscopy. Permeability of the blood-brain barrier (clearance of fluorescent-labeled dextran; molecular weight 10,000 daltons; FITC-dextran-10K) and diameter of pial arterioles were measured in the absence and presence of histamine (10 and 100 microM). During superfusion with vehicle (saline), clearance of FITC-dextran-10K from pial vessels was minimal and diameter of pial arterioles remained constant. Topical application of histamine (10 and 100 microM) produced an increase in clearance of FITC-dextran-10K and diameter of pial arterioles. To determine a potential role for nitric oxide in histamine-induced increases in permeability of the blood-brain barrier and dilatation of pial arterioles, we examined the effects of NG-monomethyl-L-arginine (L-NMMA; 10 microM). L-NMMA inhibited histamine-induced increases in permeability of the blood-brain barrier and attenuated histamine-induced dilatation of cerebral arterioles. The findings of the present study suggest that histamine increases permeability of the blood-brain barrier and diameter of pial arterioles via the synthesis/release of nitric oxide or a nitric oxide containing compound.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine / pharmacology
  • Animals
  • Arterioles / drug effects
  • Blood-Brain Barrier / drug effects
  • Blood-Brain Barrier / physiology*
  • Drug Evaluation, Preclinical
  • Histamine / pharmacology*
  • Histamine Antagonists / pharmacology
  • Molecular Weight
  • Nitric Oxide / biosynthesis
  • Nitric Oxide / physiology*
  • Rats
  • Rats, Inbred WF
  • Vasodilator Agents / pharmacology*
  • omega-N-Methylarginine / pharmacology

Substances

  • Histamine Antagonists
  • Vasodilator Agents
  • omega-N-Methylarginine
  • Nitric Oxide
  • Histamine
  • Adenosine